Tomás José González-López

12PUBLICATIONS
65CO-AUTHORS
Haematological tumoursHaematologyRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 30, 2025
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study.

Noelia Pérez-Gómez, Antonio Sanz-Solas, Beatriz Cuevas

|Aug 20, 2024
Tapering and Sustained Remission of Thrombopoietin Receptor Agonists (TPO-RAs): Is it Time for Paediatric ITP?

Susana Marcos-Peña, Beatriz Fernández-Pernia, Drew Provan

|Feb 06, 2024
The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim.

Hanny Al-Samkari, Alexandra Schifferli, Tomas J Gonzalez-Lopez

|Oct 28, 2023
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).

María Eva Mingot-Castellano, Mariana Canaro Hirnyk, Blanca Sánchez-González

|Apr 28, 2023
Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal View.

Tomás José González-López, Adrian Newland, Drew Provan

|Apr 28, 2023
Sustained Remission Off-Treatment (SROT) of TPO-RAs: The Burgos Ten-Step Eltrombopag Tapering Scheme.

Tomás José González-López, Drew Provan

Pageof 2